{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:06:26Z","timestamp":1774627586060,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06774"],"award-info":[{"award-number":["22K06774"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10113"],"award-info":[{"award-number":["25K10113"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K18649"],"award-info":[{"award-number":["25K18649"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dmpk.2025.101507","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:00:58Z","timestamp":1761843658000},"page":"101507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of blood-brain barrier permeability of drugs using forensically obtained human cerebrospinal fluid and plasma in Japan"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-5398","authenticated-orcid":false,"given":"Tomoyoshi","family":"Hariba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Mizoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sunakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-1532","authenticated-orcid":false,"given":"Yoshimichi","family":"Sai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Furumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Zuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-038X","authenticated-orcid":false,"given":"Takuo","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmpk.2025.101507_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.apsb.2019.10.001","article-title":"Current trends in drug metabolism and pharmacokinetics","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101507_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.dmpk.2025.101507_bib3","first-page":"195","article-title":"Chapter 8 - pharmacokinetic characterization of drugs and new product development","volume":"vol. 1","author":"Chatterjee","year":"2021"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101507_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI103732","article-title":"Factors influencing the concentration gradient of protein in cerebrospinal fluid","volume":"37","author":"Fishman","year":"1958","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101507_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(85)90153-4","article-title":"Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability","volume":"15","author":"Banks","year":"1985","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101507_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.118.015578","article-title":"Organic cation transporters in health and disease","volume":"72","author":"Koepsell","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101507_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmpk.2025.101507_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12987-024-00544-6","article-title":"The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells","volume":"21","author":"Svane","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101507_bib9","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/jps.22567","article-title":"Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo","volume":"100","author":"Sadiq","year":"2011","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101507_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12987-019-0158-1","article-title":"Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in alzheimer's disease","volume":"16","author":"Sekhar","year":"2019","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101507_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1991.4","article-title":"The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine","volume":"49","author":"Skjelbo","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101507_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.04126.x","article-title":"Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers","volume":"73","author":"Jensen","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101507_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10637-022-01314-7","article-title":"The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux","volume":"41","author":"Qi","year":"2023","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.dmpk.2025.101507_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00431102","article-title":"Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses","volume":"73","author":"Wode-Helgodt","year":"1981","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101507_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1124\/dmd.105.007898","article-title":"A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism","volume":"34","author":"Au-Yeung","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101507_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1213\/00000539-199809000-00020","article-title":"Lidocaine concentrations in plasma and cerebrospinal fluid after systemic bolus administration in humans","volume":"87","author":"Tsai","year":"1998","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101507_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11785-U","article-title":"Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man","volume":"195","author":"Kornhuber","year":"1995","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101507_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.1985.tb05086.x","article-title":"CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite","volume":"20","author":"Nordin","year":"1985","journal-title":"Br J Clin Pharmacol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:11:55Z","timestamp":1774624315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436725004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"alternative-id":["S1347436725004574"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101507","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of blood-brain barrier permeability of drugs using forensically obtained human cerebrospinal fluid and plasma in Japan","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of The Japanese Society for the Study of Xenobiotics.","name":"copyright","label":"Copyright"}],"article-number":"101507"}}